Rafael W. Soto-Gil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rafael W. Soto-Gil has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Pojen P. Chen
Department of Medicine, University of California/San Diego, 9500 Gilman Dr., La Jolla, CA 92093, U.S.A.
4 shared publicationsTsaiwei Olee
Department of Medicine, University of California/San Diego, 9500 Gilman Dr., La Jolla, CA 92093, U.S.A.
3 shared publicationsAnh Van Le
Ortho-Clinical Diagnostics, NJ, USA
2 shared publications- Chunni Zhang
Jinling Hospital
2 shared publications Dennis A. Carson
Department of Medicine, the Department of Pathology, and the Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, and the Department of Medicine, University of California, Davis
2 shared publicationsDick L. Robbins
Department of Medicine, the Department of Pathology, and the Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, and the Department of Medicine, University of California, Davis
2 shared publications
Latest Publications
- Open Access
- 1 October 2015
- Published by Elsevier in EBioMedicine
- Vol. 2 (10) , 1377-1385
A Five-miRNA Panel Identified From a Multicentric Case–control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients
- 1 October 2015
- Published by Elsevier in EBioMedicine
- Vol. 2 (10) , 1377-1385
Open AccessA Five-miRNA Panel Identified From a Multicentric Case–control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients
- 1 July 2015
- Published by Elsevier in European Journal of Cancer
- Vol. 51, e5
OP0016 Development of a panel of five miRNAs as a diagnostic tool for non-small-cell lung cancer
- 1 July 2015
- Published by Elsevier in European Journal of Cancer
- Vol. 51, e5
OP0016 Development of a panel of five miRNAs as a diagnostic tool for non-small-cell lung cancer
- 1 January 1994
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 39 (1) , 95-103
Utilization of a Potentially Universal Downstream Primer in the Rapid Identification and Characterization of Vβ Genes from Two New Human Vλ Gene Families
Polymerase chain reaction (PCR) has increased dramatically the speed of cloning and characterizing numerous genes. However, its application to identifying and analysing new germline Ig-variable (V) gene families has been hampered by the lack of sequence information in the downstream flanking regions of the concerned V genes, which are deleted during V(D)J rearrangements. To circumvent this problem, the possibility was explored that a degenerate downstream primer may be used in conjunction with a specific upstream primer, to clone members of new V lambda gene families, as much less is known about V lambda genes than Vh and Vk genes in humans. Firstly the feasibility and the specificity of a degenerate primer was examined by comparing it with an established downstream primer in amplifying known V lambda 1 genes. The results were positive. Thus, the degenerate primer was used to clone and characterize germline V lambda genes of the recently defined V lambda 8 and V lambda 9 gene families. This current strategy may help speed up the identification and characterization of all human V lambda genes. Moreover, a similar strategy can be applied to identify and characterize rapidly new V genes of either known or unknown Ig and T-cell receptor V gene families.
- 1 January 1994
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 39 (1) , 95-103
Utilization of a Potentially Universal Downstream Primer in the Rapid Identification and Characterization of Vβ Genes from Two New Human Vλ Gene Families
Polymerase chain reaction (PCR) has increased dramatically the speed of cloning and characterizing numerous genes. However, its application to identifying and analysing new germline Ig-variable (V) gene families has been hampered by the lack of sequence information in the downstream flanking regions of the concerned V genes, which are deleted during V(D)J rearrangements. To circumvent this problem, the possibility was explored that a degenerate downstream primer may be used in conjunction with a specific upstream primer, to clone members of new V lambda gene families, as much less is known about V lambda genes than Vh and Vk genes in humans. Firstly the feasibility and the specificity of a degenerate primer was examined by comparing it with an established downstream primer in amplifying known V lambda 1 genes. The results were positive. Thus, the degenerate primer was used to clone and characterize germline V lambda genes of the recently defined V lambda 8 and V lambda 9 gene families. This current strategy may help speed up the identification and characterization of all human V lambda genes. Moreover, a similar strategy can be applied to identify and characterize rapidly new V genes of either known or unknown Ig and T-cell receptor V gene families.
- 1 September 1992
- Published by Elsevier in Molecular Immunology
- Vol. 29 (9) , 1031-1042
Molecular characterization of the human immunoglobulin VλI germline gene repertoire
- 1 September 1992
- Published by Elsevier in Molecular Immunology
- Vol. 29 (9) , 1031-1042
Molecular characterization of the human immunoglobulin VλI germline gene repertoire
- Open Access
- 1 March 1992
- Published by Wiley in Arthritis & Rheumatism
- Vol. 35 (3) , 356-363
A systematic approach to defining the germline gene counterparts of a mutated autoantibody from a patient with rheumatoid arthritis
Objective. To define the germline counterparts of potentially highly mutated autoantibodies in disease states.Methods. We developed a systematic approach by first characterizing a rearranged Ig gene and its upstream flank, and then designing suitable primers to amplify specifically the putative germline counterpart.Results. We identified and characterized the germline counterpart of a rheumatoid factor heavy chain variable region.Conclusion. We showed unequivocally that the heavy chain of a rheumatoid factor, derived from synovial tissue, has 4 replacement mutations from the corresponding germline gene. The technique allows quick assessment of the degree of somatic mutation in many autoantibodies, and thus can help to elucidate the underlying mechanisms for the induction and sustained production of such antibodies in patients.
- 1 March 1992
- Published by Wiley in Arthritis & Rheumatism
- Vol. 35 (3) , 356-363
Open AccessA systematic approach to defining the germline gene counterparts of a mutated autoantibody from a patient with rheumatoid arthritis
Objective. To define the germline counterparts of potentially highly mutated autoantibodies in disease states.Methods. We developed a systematic approach by first characterizing a rearranged Ig gene and its upstream flank, and then designing suitable primers to amplify specifically the putative germline counterpart.Results. We identified and characterized the germline counterpart of a rheumatoid factor heavy chain variable region.Conclusion. We showed unequivocally that the heavy chain of a rheumatoid factor, derived from synovial tissue, has 4 replacement mutations from the corresponding germline gene. The technique allows quick assessment of the degree of somatic mutation in many autoantibodies, and thus can help to elucidate the underlying mechanisms for the induction and sustained production of such antibodies in patients.
- Open Access
- 1 March 1992
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 175 (3) , 831-842
Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response.
Although much has been learned about the molecular basis of immunoglobulin M (IgM) rheumatoid factors (RFs) in healthy individuals and in patients with mixed cryoglobulinemia and rheumatoid arthritis, little is known about the genetic origins of the potentially pathogenic IgG RFs in the inflamed rheumatoid synovia of patients. Recently, we generated from unmanipulated synovium B cells several hybridomas that secreted self-associating IgG RFs. To delineate the genetic origins of such potentially pathogenic RFs, we adapted the anchored polymerase chain reaction to rapidly clone and characterize the expressed Ig V genes for the L1 and the D1 IgG RFs. Then, we identified the germline counterparts of the expressed L1 IgG RF V genes. The results showed that the L1 heavy chain was encoded by a Vh gene that is expressed preferentially during early ontogenic development, and that is probably located within 240 kb upstream of the Jh locus. The overlap between this RF Vh gene and the restricted fetal antibody repertoire is reminiscent of the natural antibody-associated Vh genes, and suggests that at least part of the "potential pathogenic" IgG RFs in rheumatoid synovium may derive from the "physiological" natural antibody repertoire in a normal immune system. Indeed, the corresponding germline Vh gene for L1 encodes the heavy chain of an IgM RF found in a 19-wk-old fetal spleen. Furthermore, the comparisons of the expressed RF V genes and their germline counterparts reveal that the L1 heavy and light chain variable regions had, respectively, 16 and 7 somatic mutations, which resulted in eight and four amino acid changes. Strikingly, all eight mutations in the complementarity determining regions of the V gene-encoded regions were replacement changes, while only 6 of 11 mutations in the framework regions caused amino acid changes. Combined with L1's high binding affinity toward the Fc fragment, these results suggest strongly that the L1 IgG RF must have been driven by the Fc antigen.
- 1 March 1992
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 175 (3) , 831-842
Open AccessGenetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response.
Although much has been learned about the molecular basis of immunoglobulin M (IgM) rheumatoid factors (RFs) in healthy individuals and in patients with mixed cryoglobulinemia and rheumatoid arthritis, little is known about the genetic origins of the potentially pathogenic IgG RFs in the inflamed rheumatoid synovia of patients. Recently, we generated from unmanipulated synovium B cells several hybridomas that secreted self-associating IgG RFs. To delineate the genetic origins of such potentially pathogenic RFs, we adapted the anchored polymerase chain reaction to rapidly clone and characterize the expressed Ig V genes for the L1 and the D1 IgG RFs. Then, we identified the germline counterparts of the expressed L1 IgG RF V genes. The results showed that the L1 heavy chain was encoded by a Vh gene that is expressed preferentially during early ontogenic development, and that is probably located within 240 kb upstream of the Jh locus. The overlap between this RF Vh gene and the restricted fetal antibody repertoire is reminiscent of the natural antibody-associated Vh genes, and suggests that at least part of the "potential pathogenic" IgG RFs in rheumatoid synovium may derive from the "physiological" natural antibody repertoire in a normal immune system. Indeed, the corresponding germline Vh gene for L1 encodes the heavy chain of an IgM RF found in a 19-wk-old fetal spleen. Furthermore, the comparisons of the expressed RF V genes and their germline counterparts reveal that the L1 heavy and light chain variable regions had, respectively, 16 and 7 somatic mutations, which resulted in eight and four amino acid changes. Strikingly, all eight mutations in the complementarity determining regions of the V gene-encoded regions were replacement changes, while only 6 of 11 mutations in the framework regions caused amino acid changes. Combined with L1's high binding affinity toward the Fc fragment, these results suggest strongly that the L1 IgG RF must have been driven by the Fc antigen.
- Open Access
- 1 August 1990
- Published by Wiley in Arthritis & Rheumatism
- Vol. 33 (8) , 1188-1195
Serologic and molecular characterization of a human monoclonal rheumatoid factor derived from rheumatoid synovial cells
Molecular characterization of rheumatoid factors (RF) in rheumatoid arthritis (RA) has been hampered because of their polyclonality. To overcome this problem, we generated monoclonal RF‐secreting hybridomas from rheumatoid synovial cells. Among the RF‐secreting hybridomas, HAF10 secreted an IgM‐RF that was monospecific for human IgG. It bound well to IgG1 and IgG2, but not to IgG3 and IgG4. Sequence analysis of its heavy and light chains showed that it contained a VH1 heavy chain and a Vλ light chain that did not belong to any known λ light chain subgroup, and therefore, probably represented a new λ subgroup. These results indicated that both the heavy and light chains of a monoclonal IgM‐RF from rheumatoid synovial cells were quite different from the reported variable region sequences of several monoclonal RF derived mainly from patients with mixed cryoglobulinemia. Further studies of additional monoclonal RF from RA patients are warranted to define precisely their genetic basis and to further our understanding of the immunopathology of RA.
- 1 August 1990
- Published by Wiley in Arthritis & Rheumatism
- Vol. 33 (8) , 1188-1195
Open AccessSerologic and molecular characterization of a human monoclonal rheumatoid factor derived from rheumatoid synovial cells
Molecular characterization of rheumatoid factors (RF) in rheumatoid arthritis (RA) has been hampered because of their polyclonality. To overcome this problem, we generated monoclonal RF‐secreting hybridomas from rheumatoid synovial cells. Among the RF‐secreting hybridomas, HAF10 secreted an IgM‐RF that was monospecific for human IgG. It bound well to IgG1 and IgG2, but not to IgG3 and IgG4. Sequence analysis of its heavy and light chains showed that it contained a VH1 heavy chain and a Vλ light chain that did not belong to any known λ light chain subgroup, and therefore, probably represented a new λ subgroup. These results indicated that both the heavy and light chains of a monoclonal IgM‐RF from rheumatoid synovial cells were quite different from the reported variable region sequences of several monoclonal RF derived mainly from patients with mixed cryoglobulinemia. Further studies of additional monoclonal RF from RA patients are warranted to define precisely their genetic basis and to further our understanding of the immunopathology of RA.
- 29 June 1990
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 31 (6) , 673-678
The Early Expression of Some Human Autoantibody‐Associated Heavy Chain Variable Region Genes is Controlled by Specific Regulatory Elements
Recent molecular cloning studies have revealed that some autoantibodies may be encoded directly by germline Ig variable (V) genes without any somatic mutation, suggesting strongly that such autoantibodies are physiologically important. Independent analyses of Ig gene expression in a human fetal liver showed that only nine heavy chain V (Vh) genes were used, out of a potential germline Vh gene repertoire of 100–200. We have observed that four of these nine Vh genes encode sequences identical or almost identical to human autoantibody heavy chains. This unexpected overlap implies that some autoantibodies are expressed preferentially during early development. Recent structural analyses of two Vh3 genes expressed in fetal liver revealed many more enhancer‐like sequences in the fianking regions than expected for a typical Vh gene. It is hypothesized that these autoantibody‐related Vh genes may contain various combinations of cis regulatory elements which infiuence their specific expression during early ontogenic development. Furthermore, these observations are consistent with network hypotheses, which suggest that early B‐cell development is driven by reactivity with self. The cis regulatory elements in the autoantibody genes may act in concert with the positional effects that have been shown to facilitate Vh gene engagement.
- 29 June 1990
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 31 (6) , 673-678
The Early Expression of Some Human Autoantibody‐Associated Heavy Chain Variable Region Genes is Controlled by Specific Regulatory Elements
Recent molecular cloning studies have revealed that some autoantibodies may be encoded directly by germline Ig variable (V) genes without any somatic mutation, suggesting strongly that such autoantibodies are physiologically important. Independent analyses of Ig gene expression in a human fetal liver showed that only nine heavy chain V (Vh) genes were used, out of a potential germline Vh gene repertoire of 100–200. We have observed that four of these nine Vh genes encode sequences identical or almost identical to human autoantibody heavy chains. This unexpected overlap implies that some autoantibodies are expressed preferentially during early development. Recent structural analyses of two Vh3 genes expressed in fetal liver revealed many more enhancer‐like sequences in the fianking regions than expected for a typical Vh gene. It is hypothesized that these autoantibody‐related Vh genes may contain various combinations of cis regulatory elements which infiuence their specific expression during early ontogenic development. Furthermore, these observations are consistent with network hypotheses, which suggest that early B‐cell development is driven by reactivity with self. The cis regulatory elements in the autoantibody genes may act in concert with the positional effects that have been shown to facilitate Vh gene engagement.
- 1 January 1990
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 5 (3-4) , 239-251
From Human Autoantibodies to the Fetal Antibody Repertoire to B Cell Malignancy: It's a Small World After All
- 1 January 1990
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 5 (3-4) , 239-251
From Human Autoantibodies to the Fetal Antibody Repertoire to B Cell Malignancy: It's a Small World After All